Anti-Estrogen Therapy Achieves Complete Remission and Stability in Recurrent Cervical Cancer: A Case Study

Mun-Kun Hong; Ching-Hsing Chiang; Chiu-Hsuan Cheng; Tang-Yuan Chu

doi:10.12659/AJCR.946296

03 January 2025 : Case report Taiwan

Anti-Estrogen Therapy Achieves Complete Remission and Stability in Recurrent Cervical Cancer: A Case Study

Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents

Mun-Kun Hong^12ABCDEF, Ching-Hsing Chiang^1BEF, Chiu-Hsuan Cheng

^3BDE, Tang-Yuan Chu^124ACDEF*

DOI: 10.12659/AJCR.946296

Am J Case Rep 2025; 26:e946296

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 3. (A) FDG-PET/CT revealed recurrence of cervical carcinoma (9 months after primary CCRT). A glucose hypermetabolic lesion is located at the cervix. (B) The glucose hypermetabolic lesion completely disappeared 28 months after tamoxifen use. (C) No evidence of recurrence of cervical carcinoma on subsequent follow-up FDG-PET CT done 40 months after tamoxifen use.

Back to the Article

Anti-Estrogen Therapy Achieves Complete Remission and Stability in Recurrent Cervical Cancer: A Case Study

Your Privacy